iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
NASHUA, N.H., April 08, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today that new data indicates its AI-powered solution effectively uncovers calcium deposits in the breast vessels, a sign of possible cardiovascular disease in women. iCAD research collaborator Chirag Parghi, M.D., Chief Medical Officer of Solis Mammography, presented the findings at the American College of Cardiology (ACC) annual meeting taking place April 6 – 8, 2024, in Atlanta, GA.